Accelerating country adoption of a companion device critical for demonstrating product value




Medical affairs lead, large pharma organisation


Slow adoption of a companion device used to tailor doses of a hemophillia drug was hampering the client company's ability to demonstrate product value in a market dominated by aggressively priced competitors


Insocius designed a programme to clearly articulate customer benefits and product differentiation and then support the process for country level execution

Insocious - Blog - Chess

Identify barriers to adoption
Conducted a series of interviews with medical affairs teams to clearly articulate barriers and identify gaps in capability and evidence that needed addressing

Insocious - Blog - Chess

Customer experience journey
Built an ideal companion device + product customer experience journey to clearly show combined benefits

Insocious - Blog - Chess

Mobilisation plan
Established cross functional acceleration team to set implementation goals and agree rapid mobilisation plan with KPIs

Insocious - Blog - Chess

Best practice sharing
Set up regular online engagement meetings with functional teams to set clear expectations, track performance, trouble shoot and enable peer-learning



<60% of target physicians using companion devices in 10 countries and with limited patient groups


90% of target physicians using with over 75% of patients in 20 countries

image card

Client Feedback

“The clarity you brought to this project meant we were able to drive forward with focus, impact and real momentum. Thank you Insocius team”

Global Head of Marketing
Back to case studies